Stay updated on PSMA-617 Combo vs. SoC in Male mHSPC Clinical Trial
Sign up to get notified when there's something new on the PSMA-617 Combo vs. SoC in Male mHSPC Clinical Trial page.

Latest updates to the PSMA-617 Combo vs. SoC in Male mHSPC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAddition of 'Revision: v3.3.3' and deletion of the 'Revision: v3.3.2' entry, plus removal of the 'HHS Vulnerability Disclosure' link in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision v3.3.2 was added and v3.3.1 was removed from the history. This is a metadata update to the page's backend and does not change trial data or visible content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedThe Record History now shows a new revision v3.3.1 and removes the previous revision v3.2.0.SummaryDifference0.0%

- Check50 days agoChange DetectedRemoved the government funding and operating status notice from the page, which previously warned about possible delays and updates.SummaryDifference0.2%

- Check65 days agoChange DetectedThe history list now shows additional version entries and minor UI tweaks; core study details are unaffected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check93 days agoChange DetectedMajor change: update to v3.2.0 with a prominent notice about government funding status and operating status; removal of v3.1.0. If any time-sensitive content is shown elsewhere, it may now reflect the new version and funding status.SummaryDifference6%

Stay in the know with updates to PSMA-617 Combo vs. SoC in Male mHSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PSMA-617 Combo vs. SoC in Male mHSPC Clinical Trial page.